Published in J Med Genet on April 01, 2004
Global variation in copy number in the human genome. Nature (2006) 57.50
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 13.70
Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet (2004) 8.85
Diagnostic genome profiling in mental retardation. Am J Hum Genet (2005) 8.60
Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet (2009) 7.64
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet (2009) 7.61
Challenges and standards in integrating surveys of structural variation. Nat Genet (2007) 6.05
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87
Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet (2006) 3.70
Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One (2007) 3.53
Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet (2006) 3.29
Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet (2009) 3.25
Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. J Med Genet (2006) 2.97
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Bacterial artificial chromosome-emulation oligonucleotide arrays for targeted clinical array-comparative genomic hybridization analyses. Genet Med (2008) 2.36
SW-ARRAY: a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data. Nucleic Acids Res (2005) 2.30
Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology. J Med Genet (2005) 2.28
Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet (2007) 2.22
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
A method for accurate detection of genomic microdeletions using real-time quantitative PCR. BMC Genomics (2005) 2.04
Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics (2008) 2.00
Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet (2007) 2.00
Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays. PLoS Genet (2007) 1.95
The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet (2005) 1.94
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet (2008) 1.90
DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res (2013) 1.83
Genomic disorders ten years on. Genome Med (2009) 1.81
Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet (2008) 1.80
Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn (2006) 1.79
Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn (2009) 1.78
Hidden Markov models for the assessment of chromosomal alterations using high-throughput SNP arrays. Ann Appl Stat (2008) 1.75
Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum Genet (2006) 1.66
Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet (2005) 1.65
Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J Med Genet (2005) 1.63
DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders. Hum Mol Genet (2012) 1.50
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet (2010) 1.47
High-resolution SNP arrays in mental retardation diagnostics: how much do we gain? Eur J Hum Genet (2009) 1.46
Directly transmitted unbalanced chromosome abnormalities and euchromatic variants. J Med Genet (2005) 1.44
Review of genetic factors in intestinal malrotation. Pediatr Surg Int (2010) 1.42
Genetic studies in intellectual disability and related disorders. Nat Rev Genet (2015) 1.40
Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH. J Med Genet (2005) 1.39
Empirical Bayesian models for analysing molecular serotyping microarrays. BMC Bioinformatics (2011) 1.30
Diagnostic genome profiling: unbiased whole genome or targeted analysis? J Mol Diagn (2006) 1.30
Copy number variant analysis of human embryonic stem cells. Stem Cells (2008) 1.29
Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation. BMC Med Genet (2010) 1.29
Current developments in the genetics of autism: from phenome to genome. J Neuropathol Exp Neurol (2008) 1.26
Genetic factors in esophageal atresia, tracheo-esophageal fistula and the VACTERL association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature. Eur J Med Genet (2009) 1.26
Simultaneous discovery and testing of deletions for disease association in SNP genotyping studies. Am J Hum Genet (2007) 1.23
Cryptic genomic imbalances in patients with de novo or familial apparently balanced translocations and abnormal phenotype. Mol Cytogenet (2008) 1.23
Complex chromosome 17p rearrangements associated with low-copy repeats in two patients with congenital anomalies. Hum Genet (2007) 1.22
A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients. Eur J Hum Genet (2009) 1.20
Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays. J Med Genet (2007) 1.15
BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet (2009) 1.15
The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Dev (2013) 1.12
Reciprocal translocations: a trap for cytogenetists? Hum Genet (2005) 1.12
X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation. BMC Genomics (2007) 1.11
Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1. Cytogenet Genome Res (2009) 1.09
Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14. J Med Genet (2007) 1.06
Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling. Am J Hum Genet (2007) 1.06
A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first. Eur J Hum Genet (2009) 1.05
Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome. Am J Med Genet A (2006) 1.03
Whole-genome array-CGH for detection of submicroscopic chromosomal imbalances in children with mental retardation. Cytogenet Genome Res (2007) 1.01
Facilitating collaboration in rare genetic disorders through effective matchmaking in DECIPHER. Hum Mutat (2015) 0.99
Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet (2010) 0.98
Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenet (2010) 0.97
Construction and use of spotted large-insert clone DNA microarrays for the detection of genomic copy number changes. Nat Protoc (2007) 0.95
VACTERL Association Etiology: The Impact of de novo and Rare Copy Number Variations. Mol Syndromol (2013) 0.94
The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn (2013) 0.94
The role of rare structural variants in the genetics of autism spectrum disorders. Cytogenet Genome Res (2009) 0.93
Loss of SLC38A5 and FTSJ1 at Xp11.23 in three brothers with non-syndromic mental retardation due to a microdeletion in an unstable genomic region. Hum Genet (2007) 0.93
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom. Genomic Med (2007) 0.92
Fruit flies and intellectual disability. Fly (Austin) (2009) 0.92
An experimental loop design for the detection of constitutional chromosomal aberrations by array CGH. BMC Bioinformatics (2009) 0.91
Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns. Genome Med (2012) 0.90
Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization. Mol Cytogenet (2008) 0.89
Contribution of rare copy number variants to isolated human malformations. PLoS One (2012) 0.86
Experiences with array-based sequence capture; toward clinical applications. Eur J Hum Genet (2010) 0.86
Chromosomal map of human brain malformations. Hum Genet (2008) 0.85
What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH). Eur J Pediatr (2007) 0.84
A de novo 8.8-Mb deletion of 21q21.1-q21.3 in an autistic male with a complex rearrangement involving chromosomes 6, 10, and 21. Am J Med Genet A (2010) 0.84
Comparative genomic hybridization: microarray design and data interpretation. Methods Mol Biol (2009) 0.82
Gene-disease relationship discovery based on model-driven data integration and database view definition. Bioinformatics (2008) 0.82
Subtelomeric chromosome rearrangements in children with idiopathic mental retardation: applicability of three molecular-cytogenetic methods. Croat Med J (2006) 0.82
Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor development delay, cerebellar ataxia, and epilepsy. Hum Genet (2005) 0.81
Genetic causes of intellectual disability in a birth cohort: a population-based study. Am J Med Genet A (2015) 0.81
De novo complex intra chromosomal rearrangement after ICSI: characterisation by BACs micro array-CGH. Mol Cytogenet (2008) 0.81
Further characterization of microdeletion syndrome involving 2p15-p16.1. Am J Med Genet A (2010) 0.81
A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome. Hum Genet (2004) 0.81
Segmental duplication as one of the driving forces underlying the diversity of the human immunoglobulin heavy chain variable gene region. BMC Genomics (2011) 0.80
Use of array genomic hybridization technology for constitutional genetic diagnosis in Canada. Paediatr Child Health (2011) 0.78
Genome rearrangements detected by SNP microarrays in individuals with intellectual disability referred with possible Williams syndrome. PLoS One (2010) 0.78
Array-CGH in unclear syndromic nephropathies identifies a microdeletion in Xq22.3-q23. Pediatr Nephrol (2009) 0.78
Identification of genomic aberrations by array comparative genomic hybridization in patients with aortic dissections. Korean J Thorac Cardiovasc Surg (2011) 0.78
A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's disease. Neurogenetics (2016) 0.77
A case of de novo duplication of 15q24-q26.3. Korean J Pediatr (2011) 0.76
Disorders caused by chromosome abnormalities. Appl Clin Genet (2010) 0.76
Genetic structures of copy number variants revealed by genotyping single sperm. PLoS One (2009) 0.76
The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature (2003) 12.44
Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet (2003) 5.43
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet (2001) 4.96
DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer (2003) 4.68
The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet (1995) 4.25
Genomic microarrays in human genetic disease and cancer. Hum Mol Genet (2003) 4.15
Fully automatic quantification of microarray image data. Genome Res (2002) 3.47
High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Am J Hum Genet (2002) 3.10
The end of the beginning of chromosome ends. Am J Med Genet (2002) 3.05
Telomeres: a diagnosis at the end of the chromosomes. J Med Genet (2003) 2.52
Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29
Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet (2003) 2.15
Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci U S A (1989) 2.06
Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol (2002) 2.04
Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res (2002) 1.84
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
A unique de novo interstitial deletion del(17)(q21.3q23) in a phenotypically abnormal infant. Clin Genet (1992) 1.76
A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet (2002) 1.69
Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays. J Med Genet (2003) 1.61
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol (2003) 1.57
Definition of a critical region on chromosome 18 for congenital aural atresia by arrayCGH. Am J Hum Genet (2003) 1.52
De novo interstitial deletion del(1)(p21p32). J Med Genet (1979) 1.43
Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions. Hum Mol Genet (2003) 1.42
A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am J Hum Genet (2000) 1.39
High resolution comparative genomic hybridisation in clinical cytogenetics. J Med Genet (2001) 1.29
Interstitial deletion 1p in a 30 year old woman. J Med Genet (1987) 1.29
High-resolution genomic profiling of occult micrometastatic tumor cells. Genes Chromosomes Cancer (2003) 1.25
Two cases of interstitial deletion 1p. J Med Genet (1991) 1.21
Additional case of de novo interstitial deletion del(17)(q21.3q23) and expansion of the phenotype. Clin Genet (1993) 1.03
Neurofibromatosis pseudogene amplification underlies euchromatic cytogenetic duplications and triplications of proximal 15q. Hum Genet (1998) 1.00
Fluorescence genotyping for screening cryptic telomeric rearrangements. Methods Mol Biol (2002) 1.00
Interstitial deletion of chromosome 9, int del(9)(9q22.31-q31.2), including the genes causing multiple basal cell nevus syndrome and Robinow/brachydactyly 1 syndrome. Eur J Pediatr (2002) 0.95
Usefulness of high-resolution comparative genomic hybridization (CGH) for detecting and characterizing constitutional chromosome abnormalities. Am J Med Genet (2002) 0.93
A presumptive translocation 1p;2q resulting in duplication 1p and deletion 2q. Am J Med Genet (1989) 0.91
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics (1992) 9.06
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell (1984) 3.97
Down's syndrome births and pregnancy terminations in 1989 to 1993: preliminary findings. Br J Obstet Gynaecol (1995) 3.93
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Technique for identifying Y chromosomes in human interphase nuclei. Nature (1970) 3.64
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
Universal code equivalent of a yeast mitochondrial intron reading frame is expressed into E. coli as a specific double strand endonuclease. Cell (1986) 3.48
Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ (1993) 3.47
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer (1992) 3.03
An SNP map of human chromosome 22. Nature (2000) 2.99
Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes. Oncogene (2007) 2.91
Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain. J Med Genet (2004) 2.83
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Purification and characterization of the in vitro activity of I-Sce I, a novel and highly specific endonuclease encoded by a group I intron. Nucleic Acids Res (1990) 2.79
Association of cervical artery dissection with recent infection. Arch Neurol (1999) 2.63
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Telomeres: a diagnosis at the end of the chromosomes. J Med Genet (2003) 2.52
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Lancet (1979) 2.42
Vibration and praise as reinforcers for mentally handicapped people. Ment Retard (1978) 2.38
19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet (2009) 2.37
The new genetics. Implications for clinical services in Britain and the United States. BMJ (1998) 2.30
The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature (1975) 2.29
Differential staining of human and mouse chromosomes in interspecific cell hybrids. Nature (1974) 2.28
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J Virol (1996) 2.28
Analysis of national register of Down's syndrome in England and Wales: trends in prenatal diagnosis, 1989-91. BMJ (1993) 2.21
Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome. Lancet (1993) 2.20
An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet (1998) 2.16
Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet (1995) 2.12
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis (2004) 2.09
Results of first year (1989) of a national register of Down's syndrome in England and Wales. BMJ (1991) 2.07
Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet (2001) 2.07
Antenatal screening in Oxford for fetal neural tube defects. Br J Obstet Gynaecol (1979) 2.06
Two cases of X/autosome translocation in females with incontinentia pigmenti. Hum Genet (1985) 2.05
The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet (2005) 1.94
Staining of some specific regions of human chromosomes, particularly the secondary constriction of No. 9. Nat New Biol (1972) 1.91
Parents' responses to predictive genetic testing in their children: report of a single case study. J Med Genet (1996) 1.83
Ontologies of developmental anatomy: their current and future roles. Brief Bioinform (2001) 1.82
Reciprocal translocations in man. 3:1 Meiotic disjunction resulting in 47- or 45-chromosome offspring. J Med Genet (1975) 1.81
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet (1994) 1.81
A comparative study of karyotypes of muntjacs by chromosome painting. Chromosoma (1995) 1.81
Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet (1996) 1.79
Definitive evidence for the short arm of the Y chromosome associating with the X chromosome during miosis in the human male. Nature (1970) 1.78
Genetics of classic Alport's syndrome. Lancet (1988) 1.73
Quantitative fluorescence polymerase chain reaction for the rapid prenatal detection of common aneuploidies and fetal sex. Am J Obstet Gynecol (1997) 1.69
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J Med Genet (2005) 1.63
Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays. J Med Genet (2003) 1.61
Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke (1998) 1.60
Previously apparently undescribed syndrome: shallow orbits, ptosis, coloboma, trigonocephaly, gyral malformations, and mental and growth retardation. Am J Med Genet (1995) 1.56
Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet (1996) 1.55
Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer (1997) 1.55
Prenatal testing for Duchenne and Becker muscular dystrophy. Lancet (1988) 1.54
Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial. Gynecol Oncol (1999) 1.54
CT angiography and Doppler sonography for emergency assessment in acute basilar artery ischemia. Stroke (1999) 1.48
Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle. Epidemiol Infect (1996) 1.48
Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology (1994) 1.47
A method for generating hybrids containing nonselected fragments of human chromosomes. Genomics (1989) 1.47
Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A (1992) 1.46
Comparison of bronchoalveolar lavage and catheter lavage to confirm ventilator-associated lower respiratory tract infection. J Med Microbiol (1996) 1.46
Chromosome assignment of some human enzyme loci: mitochondrial malate dehydrogenase to 7, mannosephosphate isomerase and pyruvate kinase to 15 and probably, esterase D to 13. Ann Hum Genet (1975) 1.45
Exon structure of the human dystrophin gene. Genomics (1993) 1.45
Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet (2001) 1.44
Human gene mapping using an X/autosome translocation. Somatic Cell Genet (1976) 1.44
Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA. Lancet (1991) 1.44
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer (2007) 1.43
Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet (1998) 1.42
[Current state of mechanical corneal surgery - results of a questionnaire to members of the cornea section of the German Society of Ophthalmologists]. Klin Monbl Augenheilkd (2006) 1.42
Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet (1991) 1.41
Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene (2006) 1.40
Abnormal chromosome complement after normal amniocentesis result. Lancet (1992) 1.40
Objectives of genetic counselling: differing views of purchasers, providers and users. J Public Health Med (1998) 1.38
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
Evidence for a new X-linked mental retardation gene in Xp21-Xp22: clinical and molecular data in one family. Am J Med Genet (1999) 1.38
Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat (1994) 1.36
Detection of novel genetic markers by mismatch analysis. Nucleic Acids Res (1989) 1.36
Effect of purified luteinizing hormone releasing factor on normal and hypogonadotrophic anosmic men. Nature (1971) 1.36
Chromosomal factors of infertility in candidate couples for ICSI: an equal risk of constitutional aberrations in women and men. Hum Reprod (2001) 1.34
Reciprocal chromosome painting reveals detailed regions of conserved synteny between the karyotypes of the domestic dog (Canis familiaris) and human. Genomics (1999) 1.34
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Genetic counselling: the psychological impact of meeting patients' expectations. J Med Genet (1997) 1.33